Future studies including in vivo experiments will clarify the role of TRPM4 in cancer, will elucidate the regulatory mechanisms it employs to sustain CSCs and will evaluate its potential as a therapeutic target in breast tumors. The gene discussed is TRPM4; the disease is cancer.